A carregar...
Efficacy of Panobinostat for the Treatment of Multiple Myeloma
Panobinostat represents a potent oral nonselective pan-histone deacetylase inhibitor (HDAC) with activity in myeloma patients. It has been approved by the FDA and EMA in combination with bortezomib and dexamethasone for the treatment of multiple myeloma, in patients who have received at least two pr...
Na minha lista:
| Publicado no: | J Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7201625/ https://ncbi.nlm.nih.gov/pubmed/32411240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7131802 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|